Drug profile · INN
meclofenamate sodium
MECLOFENAMATE SODIUM
meclofenamate sodium (MECLOFENAMATE SODIUM) is a arachidonate 5-lipoxygenase inhibitor. Associated with Quantum Biopharma. Route of administration: oral. Current US regulatory status: approved.
Drug details — meclofenamate sodium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
meclofenamate sodium (MECLOFENAMATE SODIUM) is a arachidonate 5-lipoxygenase inhibitor. Associated with Quantum Biopharma. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Arachidonate 5-lipoxygenase inhibitor
Primary target: Polyunsaturated fatty acid 5-lipoxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is meclofenamate sodium?
meclofenamate sodium (MECLOFENAMATE SODIUM) is a arachidonate 5-lipoxygenase inhibitor. Associated with Quantum Biopharma. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for meclofenamate sodium?
MECLOFENAMATE SODIUM is a marketed brand name for meclofenamate sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of meclofenamate sodium?
meclofenamate sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.